SCHEMBL20609355

SCHEMBL20609355

CC1CCCCCCN1N

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
HPGD P15428 2/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
RECQL P46063 1/20 0.35
GAA P10253 3/20 0.35
SMN1; SMN2 Q16637 1/20 0.33
ACHE P22303 3/20 0.33
BCHE P06276 1/20 0.33
PKM P14618 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
CHRM5 P08912 1/20 0.32
ADRA2C P18825 1/20 0.32
NPC1 O15118 1/20 0.32
HTT P42858 1/20 0.32
TSHR P16473 1/20 0.31
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA7 P43166 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopropane SCHEMBL11122692 1.00 ALDH1A1 (0.36) ALDH1A1HPGDMEN1KMT2ARECQL
SCHEMBL12808264 1.00
SCHEMBL3455746 0.97
SCHEMBL20284520 0.97
SCHEMBL8258133 0.97
Bromide SCHEMBL7065185 0.95
Hydrochloric Acid SCHEMBL4283459 0.95
SCHEMBL8757826 0.89
SCHEMBL14747926 0.89
SCHEMBL3611735 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10170710-B2 Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2019-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10170710-B2 Organometallic complex, light-emitting element, light-emitting device, electronic device, and lighting device CALCOCO2, CYBA, INTS9 ALDH1A1 2102/4885HPGD 2340/4885MEN1 2141/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.